For OS, HER2 expression showed a similar negative trend but did not reach statistical significance (adjusted HR = 1.27, 95% CI: 0.99–1.62, p = 0.058).
← all excerpts
First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort.
1
0.0580
0.0580